OVERVIEW

John Theurer Cancer presents the 2022 San Antonio Breast Cancer Review: This program, based on data presented at the San Antonio Breast Cancer Symposium 2022, is designed to provide a review of state of the art information on experimental biology, etiology, prevention, diagnosis & therapy of breast cancer/premalignant breast disease to an audience of academic and private physicians and researchers involved in medical, surgical, GYN and radiation therapy, as well as other appropriate health care professionals.

TARGET AUDIENCE

Physicians, Physician Assistants, Nurse Practitioners, Nurses, Fellows, Residents and Students.

LEARNING OBJECTIVES

1. Identify patients with Oligo metastic disease that are candidates for breast cancer surgery;
2. Define patients best suited for APBI and proton beam therapy in metastic breast cancer;
3. Determine patients that do not need post breast surgery radiation;
4. List the differences in 3DK4/6 inhibitors and determine which one to use;
5. Determine the role of CDK 4 inhibitors in the adjuvant area;
6. Explain the future role of oral taxains;
7. Apply next gen. sequencing for the treatment of metastatic and adjuvant breast cancer;
8. Summarize the use of sacituzumab in triple negative breast cancer.

ACCREDITATION

Hackensack Meridian Health is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Hackensack Meridian Health designates this live activity for a maximum of  6.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.